Phase II marker lesion study with intravesical instillation of apaziquone for superficial bladder cancer: Toxicity and marker response - Editorial comment

Karlheinz Kurth

Research output: Contribution to JournalEditorialAcademicpeer-review

Original languageEnglish
Pages (from-to)1353
JournalJournal of Urology
Volume176
Issue number4 Part 1
DOIs
Publication statusPublished - 2006

Cite this